FAIS, FRANCO
 Distribuzione geografica
Continente #
EU - Europa 10.515
NA - Nord America 1.415
AS - Asia 1.389
Continente sconosciuto - Info sul continente non disponibili 161
SA - Sud America 142
AF - Africa 33
OC - Oceania 1
Totale 13.656
Nazione #
IT - Italia 10.289
US - Stati Uniti d'America 1.318
SG - Singapore 516
CN - Cina 349
VN - Vietnam 244
BD - Bangladesh 133
FR - Francia 87
BR - Brasile 85
HK - Hong Kong 48
CA - Canada 40
DE - Germania 33
AR - Argentina 26
FI - Finlandia 24
JM - Giamaica 16
JP - Giappone 16
GB - Regno Unito 14
CH - Svizzera 13
ID - Indonesia 13
IQ - Iraq 13
MX - Messico 12
ZA - Sudafrica 11
CO - Colombia 9
CR - Costa Rica 9
IN - India 8
RU - Federazione Russa 8
UA - Ucraina 8
ES - Italia 7
PK - Pakistan 7
PH - Filippine 6
TR - Turchia 6
DZ - Algeria 5
EC - Ecuador 5
IE - Irlanda 5
NL - Olanda 5
GT - Guatemala 4
HN - Honduras 4
NI - Nicaragua 4
PE - Perù 4
SA - Arabia Saudita 4
BO - Bolivia 3
CL - Cile 3
EG - Egitto 3
KZ - Kazakistan 3
MA - Marocco 3
MY - Malesia 3
PL - Polonia 3
PY - Paraguay 3
RS - Serbia 3
SV - El Salvador 3
TW - Taiwan 3
VE - Venezuela 3
AL - Albania 2
AT - Austria 2
BH - Bahrain 2
CW - ???statistics.table.value.countryCode.CW??? 2
JO - Giordania 2
KE - Kenya 2
LC - Santa Lucia 2
NG - Nigeria 2
RO - Romania 2
TH - Thailandia 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BF - Burkina Faso 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GD - Grenada 1
GF - Guiana Francese 1
GR - Grecia 1
HR - Croazia 1
HT - Haiti 1
IS - Islanda 1
KW - Kuwait 1
LB - Libano 1
MD - Moldavia 1
MZ - Mozambico 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
QA - Qatar 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
SO - Somalia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 13.497
Città #
Genova 5.276
Genoa 3.206
Rapallo 878
Vado Ligure 754
San Jose 356
Singapore 241
Ashburn 169
Lauterbourg 79
Ho Chi Minh City 72
Beijing 64
Hanoi 48
Hong Kong 43
New York 41
Los Angeles 30
Santa Clara 29
Council Bluffs 27
Helsinki 24
Frankfurt am Main 22
Milan 20
Bordighera 19
Buffalo 16
Dallas 15
Tokyo 14
Boardman 12
Da Nang 12
Bologna 11
St Louis 11
Zurich 11
Brasília 10
Rome 10
Chicago 9
Kingston 9
Mexico City 9
Orem 9
Guangzhou 8
Haiphong 8
Philadelphia 8
Phoenix 8
Queens 8
São Paulo 8
Atlanta 7
San José 7
Turin 7
Biên Hòa 6
Cincinnati 6
City of London 6
Dublin 6
Johannesburg 6
Madrid 6
Nuremberg 6
The Bronx 6
Toronto 6
Brooklyn 5
Hixson 5
Montreal 5
Naples 5
Seattle 5
Baghdad 4
Charlotte 4
Chennai 4
Figino 4
Kyiv 4
Managua 4
Miami 4
San Francisco 4
Tampa 4
Tianjin 4
Almaty 3
Augusta 3
Aurora 3
Bari 3
Brampton 3
Bắc Ninh 3
Cairo 3
Can Tho 3
Cape Coral 3
Cape Town 3
Changsha 3
Chula Vista 3
Cochabamba 3
Denver 3
Dhaka 3
Egg Harbor Township 3
Garland 3
Guatemala City 3
Houston 3
Kansas City 3
Leander 3
London 3
Milwaukee 3
Minneapolis 3
Moscow 3
Newark 3
Nha Trang 3
Ninh Bình 3
Padua 3
Phú Thọ 3
Phủ Lý 3
Pordenone 3
Rochester Hills 3
Totale 11.843
Nome #
A reversible carnitine palmitoyltransferase (CPT1) inhibitor offsets the proliferation of chronic lymphocytic leukemia cells 244
Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells. 234
N-(4-hydroxyphenyl) retinamide promotes apoptosis of resting and proliferating B-cell chronic lymphocytic leukemia cells and potentiates Fludarabine and ABT-737 cytotoxicity 226
B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. 207
Human cytomegalovirus regulates surface expression of the viral protein UL18 by means of two motifs present in the cytoplasmic tail. 202
A Vector Design that Allows Fast and Convenient Production of Differently Tagged Proteins. 202
Recruitment of a host's osteoprogenitor cells using exogenous mesenchymal stem cells seeded on porous ceramic 194
Discovery of a novel glucose metabolism in cancer: The role of endoplasmic reticulum beyond glycolysis and pentose phosphate shunt 191
Chronic lymphocytic leukemia: a proliferation of B cells at two distinct stages of differentiation 189
Apoptosis of Burkitt's lymphoma cells induced by specific interaction of surface IgM with a self-antigen: implications for lymphomagenesis in acquired immunodeficiency syndrome. 189
BH3-only proteins: the death-puppeteer's wires 188
A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI) 187
Berberine affects mitochondrial activity and cell growth of leukemic cells from chronic lymphocytic leukemia patients 185
PML gene is not involved in the regulation of MHC class I expression in human cell lines. 183
Igs expressed by chronic lymphocytic leukemia B cells show limited binding-site structure variability. 183
Apoptosis of B-cell chronic lymphocytic leukemia cells induced by a novel BH3 peptidomimetic 179
Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolence 179
Cellular mechanisms of artificial peptides binding to HLA. 177
High frequency of development of B cell lymphoproliferation and diffuse large B cell lymphoma in Dbl knock-in mice. 176
CD1d expression and function in B-cell lymphoproliferative disorders 176
Characterizing Features of Human Circulating B Cells Carrying CLL-Like Stereotyped Immunoglobulin Rearrangements 174
CX3CR1 is expressed by human B lymphocytes and mediates CX3CL1 driven chemotaxis of tonsil centrocytes. 173
Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. 166
Development of sarcomas in mice implanted with mesenchymal stem cells seeded onto bioscaffolds 166
Functional Activation of Osteoclast Commitment in Chronic Lymphocytic Leukaemia: A Possible Role for RANK/RANKL Pathway 165
Analysis of the stepwise genetic changes that occurred in an AIDS-related Burkitt\'s lymphoma. 163
Expression of Ig receptors with distinctive features indicating antigen selection by marginal zone B cells from human spleen. 162
The recruitment of two consecutive and different waves of host stem/progenitor cells during the development of tissue-engineered bone in a murine model 162
Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy 161
Deciphering KRAS and NRAS mutated clone dynamics in MLL-AF4 paediatric leukaemia by ultra deep sequencing analysis 160
SH3BGRL3 binds to myosin 1c in a calcium dependent manner and modulates migration in the MDA-MB-231 cell line 156
Analysis of stepwise genetic changes in an AIDS-related Burkitt's lymphoma. 155
A soluble form of CTLA-4 is present in serum of paediatric patients with acute lymphoblastic leukaemia. 154
Chronic lymphocytic leukemia cells impair osteoblastogenesis and promote osteoclastogenesis: role of TNFα, IL-6 and IL-11 cytokines 154
Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia 153
Tracing CLL-biased stereotyped immunoglobulin gene rearrangements in normal B cell subsets using a high-throughput immunogenetic approach 153
Apoptosis of Burkitt\'s lymphoma cells induced by specific interaction of surface IgM with a self-antigen. Implications for lymphomagenesis in AIDS. 151
Adoptive immunotherapy mediated by ex vivo expanded NKT cells against CD1D-expressing lymphoid neoplasms. 149
Evidence for progenitors of chronic lymphocytic leukemia B cells that undergo intraclonal differentiation and diversification. 147
Effects of fatty acid oxidation inhibitors on in vitro stimulated Chronic Lymphocytic Leukemia cells 147
Inhibitory receptors CD85j, LAIR-1 and CD152 down-regulate immunoglobulin and cytokine production by human B lymphocytes 146
Establishment and characterization of a novel fibroblastic cell line (Sci13d) derived from the broncho-alveolar lavage of a patient with fibrotic hypersensitivity pneumonitis 146
Targeting the p53/xCT/GSH Axis with PRIMA-1Met Combined with Sulfasalazine Shows Therapeutic Potential in Chronic Lymphocytic Leukemia 145
Immunoglobulin V region gene use and structure suggest antigen selection in AIDS-related primary effusion lymphomas 141
Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy. 141
CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates α-galactosylceramide presentation to natural killer T lymphocytes 141
Similarities and differences between the light and heavy chain Ig variable region gene repertoires in chronic lymphocytic leukaemia. 140
Trends in Stem Cell Proliferation and Cancer Research: BH3-only proteins in cancer and apoptosis 139
Unexpected chronic lymphocytic leukemia B cell activation by bisphosphonates 138
Mutation pattern of paired immunoglobulin heavy and light variable domains in chronic lymphocytic leukemia B-cells 138
Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia 135
Identification of three subgroups of B-CELL chronic lymphocytic leukemia based upon mutations of BCL-6 and Ig V genes 134
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients 132
IMMUNOGLOBULIN V GENE MUTAITON STATUS AND CD38 EXPRESSION AS NOVEL PROGNOSTIC INDICATORS IN CHRONIC LYMPHOCYTIC LEUKEMIA 131
Transfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblasts. 131
Defective stromal remodeling and neutrophil extracellular traps in lymphoid tissues favor the transition from autoimmunity to lymphoma. 130
Inhibitory receptors CD85j, LAIR-1, and CD152 down-regulate immunoglobulin and cytokine production by human B lymphocytes 130
Hepatocyte growth factor: A microenvironmental resource for leukemic cell growth 130
Dependence of immunoglobulin class switch recombination in B cells on vesicular release of ATP and CD73 ectonucleotidase activity. 128
CD1d expression on B-precursor acute lymphoblastic leukemia subsets with poor prognosis 127
Restricted immunoglobulin VH region repertoire in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia. 121
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL 121
Immunoglobulin V genes and CD38 expression analysis in B cell chronic lymphocytic leukemia. Blood. Letter 120
Role of the B-cell receptor in chronic lymphocytic leukemia: where do we stand? 120
Assessment of RT-PCR detection of human mammaglobin for the disgnosis of breast cancer derived pleural effusion. 120
IgV gene intraclonal diversification and clonal evolution in B-cell chronic lymphocytic leukaemia 119
A High Percentage of CD16+ Monocytes Correlates with the Extent of Bone Erosion in Chronic Lymphocytic Leukemia Patients: The Impact of Leukemic B Cells in Monocyte Differentiation and Osteoclast Maturation 118
Effect of blocking or cross-linking of inhibitory receptors on T cell proliferation and cytokine production. 117
Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases 117
Abstract IgH and L chain variable region gene sequence analyses of twelve synovial tissue-derived B cell lines producing IgA, IgG, and IgM rheumatoid factors structure/function comparisons of antigenic specificity, V gene sequence, and Ig isotype. 116
TRANSFECTION OF THE C-MYC ONCOGENE INTO NORMAL EBV-HARBORING B CELLS RESULTS IN NEW PHENOTYPIC AND FUNCTIONAL FEATURES RESEMBLING THOSE OF BURKITT LYMPHOMA CELLS AND NORMAL CENTROBLASTS 115
Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter? 115
Case Report: Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights 110
Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia 106
Relationship between human mammaglobin mRNA expression in breast cancer tissue and clinico-pathologic features of the tumors. 105
Antitumor effects of PRIMA-1 and PRIMA-1met (APR246) in hematological malignancies: Still a mutant p53-dependent affair? 105
Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood. 101
LINC00152 expression in normal and Chronic Lymphocytic Leukemia B cells 100
A Soluble Form of CTLA-4 Is Present in Paediatric Patients with Acute Lymphoblastic Leukaemia and Correlates with CD1d+ Expression 99
Examples of in vivo isotype switching in IgM+ chronic lymphocytic leukemia B cells 99
Targeting the Bcl-2 family in B-cell chronic lymphocytic leukemia 99
TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors 98
BH3-only proteins in cancer and apoptosis 91
A pilot study on school of medicine students’ perception of ethical issues related to human specimens in anatomical museums 88
MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study 87
La forma solubile di CTLA-4 è espressa nel siero di pazienti pediatrici affetti da leucemia linfoblastica acuta. 84
Computational-based PET/CT evaluation can detect and stage the metabolic changes linked to the RANK/RANKL loop, in chronic lymphocytic leukemia 83
Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cells 82
Old and New Facts and Speculations on the Role of the B Cell Receptor in the Origin of Chronic Lymphocytic Leukemia 81
Post-Transformation IGHV-IGHD-IGHJ Mutations in Chronic Lymphocytic Leukemia B Cells: Implications for Mutational Mechanisms and Impact on Clinical Course 79
null 78
Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. 58
Validation of the Alternative International Prognostic Score-E (AIPS-E): Analysis of Binet stage A chronic lymphocytic leukemia patients enrolled into the O-CLL1-GISL protocol 58
The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective study 57
Unraveling the bone-tissue microenvironment in Chronic Lymphocytic Leukemia 57
MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cells 56
Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia 56
Identification of three subgroups of B cell chronic lymphocytic leukemia based upon mutations of BCL-6 and lgV genes 51
Ig h and l chain variable region gene sequence analyses of twelve synovial tissue-derived b cell lines producing iga, igg, and igm rheumatoid factors structure/function comparisons of antigenic specificity, v gene sequence, and IG isotype 50
Chronic lymphocytic leukemia often arises by a multiclonal selection process 48
Totale 13.470
Categoria #
all - tutte 47.289
article - articoli 44.259
book - libri 0
conference - conferenze 2.604
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 426
Totale 94.578


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022889 0 0 74 100 39 66 64 232 33 92 53 136
2022/20231.102 113 102 11 142 153 176 4 114 157 7 102 21
2023/2024802 30 85 22 80 79 169 67 53 41 19 56 101
2024/20251.996 73 139 61 145 214 210 207 326 70 85 228 238
2025/20263.741 465 103 212 307 481 284 564 207 222 406 254 236
2026/2027640 352 112 176 0 0 0 0 0 0 0 0 0
Totale 13.656